| Genetic mechanisms of critical illness in COVID-19 E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ... Nature 591 (7848), 92-98, 2021 | 1463 | 2021 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 310 | 2022 |
| ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population E Benetti, R Tita, O Spiga, A Ciolfi, G Birolo, A Bruselles, G Doddato, ... European Journal of Human Genetics 28 (11), 1602-1614, 2020 | 279 | 2020 |
| Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study C Fallerini, S Daga, S Mantovani, E Benetti, N Picchiotti, D Francisci, ... elife 10, e67569, 2021 | 198 | 2021 |
| Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer … S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ... The Lancet Respiratory Medicine 10 (2), 167-179, 2022 | 161 | 2022 |
| Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 M d'Alessandro, P Cameli, RM Refini, L Bergantini, V Alonzi, N Lanzarone, ... Journal of medical virology 92 (10), 2216-2220, 2020 | 110 | 2020 |
| Long-term follow-up of patients with idiopathic pulmonary fibrosis treated with pirfenidone or nintedanib: a real-life comparison study P Cameli, RM Refini, L Bergantini, M d’Alessandro, V Alonzi, C Magnoni, ... Frontiers in Molecular Biosciences 7, 581828, 2020 | 77 | 2020 |
| Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review M d’Alessandro, L Bergantini, P Cameli, L Vietri, N Lanzarone, V Alonzi, ... Biomarkers in Medicine 14 (8), 665-674, 2020 | 72 | 2020 |
| Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis D Bennett, P Cameli, N Lanzarone, L Carobene, N Bianchi, A Fui, L Rizzi, ... Respiratory research 21, 1-12, 2020 | 71 | 2020 |
| Effects of rituximab therapy on B cell differentiation and depletion L Bergantini, M d’Alessandro, P Cameli, L Vietri, C Vagaggini, A Perrone, ... Clinical Rheumatology 39, 1415-1421, 2020 | 68 | 2020 |
| BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases M d’Alessandro, A Carleo, P Cameli, L Bergantini, A Perrone, L Vietri, ... Clinical and experimental medicine 20, 207-216, 2020 | 68 | 2020 |
| Metabolic dysregulation in idiopathic pulmonary fibrosis E Bargagli, RM Refini, M d’Alessandro, L Bergantini, P Cameli, ... International Journal of Molecular Sciences 21 (16), 5663, 2020 | 62 | 2020 |
| Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males M Baldassarri, N Picchiotti, F Fava, C Fallerini, E Benetti, S Daga, ... EBioMedicine 65, 2021 | 60 | 2021 |
| Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting M d'Alessandro, F Perillo, RM Refini, L Bergantini, F Bellisai, E Selvi, ... International Immunopharmacology 86, 106748, 2020 | 55 | 2020 |
| Serum amyloid A: A potential biomarker of lung disorders L Vietri, A Fui, L Bergantini, M d’Alessandro, P Cameli, P Sestini, P Rottoli, ... Respiratory Investigation 58 (1), 21-27, 2020 | 52 | 2020 |
| Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women M Monticelli, B Hay Mele, E Benetti, C Fallerini, M Baldassarri, S Furini, ... Genes 12 (4), 596, 2021 | 50 | 2021 |
| Serial KL-6 measurements in COVID-19 patients M d’Alessandro, L Bergantini, P Cameli, G Curatola, L Remediani, ... Internal and emergency medicine, 1-5, 2021 | 49 | 2021 |
| Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy M d’Alessandro, L Bergantini, P Cameli, M Pieroni, RM Refini, P Sestini, ... Cancers 13 (4), 689, 2021 | 49 | 2021 |
| NK and NKT-like cells in granulomatous and fibrotic lung diseases L Bergantini, P Cameli, M d’Alessandro, C Vagaggini, RM Refini, C Landi, ... Clinical and Experimental Medicine 19, 487-494, 2019 | 49 | 2019 |
| Prognostic bioindicators in severe COVID-19 patients L Bergantini, E Bargagli, M d'Alessandro, RM Refini, P Cameli, L Galasso, ... Cytokine 141, 155455, 2021 | 47 | 2021 |
elena bargagliUniversità di SienaEmail verificata su unisi.it